Recent studies indicated that PF improved insulin resistance (IR) in NAFLD animal models by promoting fatty acid oxidation through the activation of peroxisome proliferator-activated receptor-alpha (PPARα)13 and by increasing the activity of AMP-activated protein kinase (AMPK)14. Here, PPARA is linked to metabolic dysfunction-associated steatotic liver disease.